DaVita Inc. stock gains as guidance and earnings support strong 2026 outlook

Published on 09/09/2026 at 23:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DaVita Inc. stock closed at USD 183.54 on September 9, 2026 on its primary US exchange, up 1.90% and more than 60% year to date. The company is guiding for adjusted EPS between USD 14.10 and 15.20 in 2026 after Q2 2026 revenue of USD 3.55 billion beat forecasts.

Modernes Dialysezentrum mit Pflegepersonal und Patienten in heller Klinikumgebung — DaVita Inc. Dialysezentrum mit modernen Behandlungsstühlen und medizinischem Pflegepersonal in Denver, ISIN US23918K1088, Illustration mit AI erstellt.

DaVita Inc. stock (ISIN US23918K1088) traded at USD 183.54 on September 9, 2026 on its primary US exchange, corresponding to a 1.90% gain for the session and a year-to-date increase of 61.81% that significantly outpaces the broader health-care space.

Q2 2026 figures and 2026 guidance underpin the rally

According to MarketScreener on August 4, 2026, DaVita reported second-quarter 2026 revenue of USD 3.55 billion, coming in above analysts' expectations and marking a solid advance versus the prior-year period.

In the same Q2 2026 release, adjusted earnings per share increased, and the company raised its full-year 2026 guidance, now forecasting adjusted EPS between USD 14.10 and 15.20, compared with a FactSet consensus of USD 14.88 at the time, signaling management's confidence in the earnings trajectory.MarketScreener

As Zacks reported on September 9, 2026, the consensus estimate for DaVita's third-quarter 2026 revenue stands at USD 3.53 billion, implying a 3.2% increase from the year-ago quarter, while the consensus for Q3 2026 earnings is USD 3.78 per share, pointing to 50.6% year-over-year growth.

Estimates and stock performance highlight investor confidence

Zacks noted on September 9, 2026 that the 2026 consensus earnings estimate of USD 14.57 per share has remained stable over the past 30 days, suggesting that analysts largely endorse the upgraded guidance and see limited downside to the profit outlook in the near term.Zacks

The same analysis indicated that DaVita stock had rallied 58.5% year to date at the time of publication, beating the industry’s 22% gain and the S&P 500’s 11.6% advance, underlining the market's preference for the company relative to both its sector and the broader equity benchmark.Zacks

For investors, the combination of mid-single-digit expected revenue growth in Q3 2026 and more than 50% projected earnings growth year over year suggests that margin expansion and operational efficiency improvements are key drivers behind DaVita's strong share-price performance, rather than topline growth alone.

Recent price action and valuation context

Price data from MarketScreener show that DaVita stock closed at USD 183.54 on September 9, 2026 on its primary US exchange, up 1.90% from the previous close of USD 180.11, after earlier closes of USD 183.98 on September 4, 2026 and USD 181.86 on September 3, 2026, illustrating a pattern of resilience around the USD 180 to 184 band.MarketScreener

The same overview indicates that as of September 9, 2026, DaVita's shares were up 61.81% since the start of the year, while the five-day performance stood at 1.77%, reflecting both a strong longer-term trend and a modest positive short-term move that keeps the stock near its recent highs.MarketScreener

Given the 2026 adjusted EPS guidance range of USD 14.10 to 15.20 and the consensus EPS estimate of USD 14.57 for 2026, the current price level implies that the market is willing to pay a premium for DaVita's earnings profile compared with many peers, especially in light of the projected 50.6% year-over-year earnings growth for Q3 2026.

Stock price snapshot

DaVita Inc. stock last closed at USD 183.54 on its primary US exchange on September 9, 2026, with a daily gain of 1.90% and a year-to-date performance of 61.81%, offering investors a clear picture of the current valuation against the backdrop of strengthened 2026 earnings guidance.